Tag: COVID-19

Gufic Biosciences gets DCGI nod for Thymosin Alpha-1 in Covid-19

businessnewstoday- April 5, 2022 0

Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment ... Read More

AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention

businessnewstoday- March 18, 2022 0

AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More

Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment

businessnewstoday- March 18, 2022 0

Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More

US NIH stops ACTIV-2 phase 3 trial of Covid-19 drug candidate SAB-185

businessnewstoday- March 6, 2022 0

SAB Biotherapeutics said that the US National Institutes of Health (NIH) is discontinuing the phase 3 ACTIV-2 trial of the company’s SAB-185 for the treatment ... Read More

Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine

businessnewstoday- February 27, 2022 0

Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as ... Read More

Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio

businessnewstoday- February 20, 2022 0

Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More

Hinduja Global Solutions bags contract worth up to £211m from UKHSA

businessnewstoday- February 20, 2022 0

Hinduja Global Solutions (HGS) said that its subsidiary HGS UK has bagged a contract worth up to £211 million (INR 2,100 crores) from the UK ... Read More

Lilly, US govt sign deal for 600,000 doses of Covid-19 drug bebtelovimab

businessnewstoday- February 13, 2022 0

Eli Lilly and Company (Lilly) has signed a deal worth at least $720 million with the US government to deliver up to 600,000 doses of ... Read More

Australia’s Talon Energy to exit from UK North Sea exploration

businessnewstoday- February 13, 2022 0

Talon Energy said that it has decided to launch an exit of its portfolio of exploration assets in the UK North Sea based on an ... Read More

Novavax reports success for NVX-CoV2373 in pediatric group of phase 3 trial

businessnewstoday- February 13, 2022 0

Novavax said that its Covid-19 vaccine NVX-CoV2373 achieved its primary effectiveness endpoint in the pediatric expansion of its phase 3 PREVENT-19 trial. According to the ... Read More